NEW YORK, Aug 7 – Amersham Pharmacia of London said Tuesday its Amersham Pharmacia Biotech unit posted overall sales of 325.1 million pounds ($460.2 million) in the first half of the year, up 13 percent from the same period a year ago.

Within APBiotech, the company reported a 22 percent increase in its protein purification separations business to 130 million pounds, a one percent increase in sales of laboratory products to 93 million pounds, and a nine percent increase in drug discovery sales to 71 million pounds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.